| Literature DB >> 33129293 |
Tesfaye Getachew Charkos1, Yawen Liu1, Kemal Sherefa Oumer1, Ann M Vuong2, Shuman Yang3.
Abstract
BACKGROUND: Epidemiological studies examining the association between β-carotene intake and risk of fracture have reported inconsistent findings. We conducted a meta-analysis to investigate the association between β-carotene intake and risk of fracture.Entities:
Keywords: Bayesian; Fracture; Meta-analysis; Osteoporosis; Vitamin a; β-Carotene
Mesh:
Substances:
Year: 2020 PMID: 33129293 PMCID: PMC7603770 DOI: 10.1186/s12891-020-03733-0
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flow chart for study inclusion and exclusion
Characteristics of included studies examining the association between β-carotene intake and risk of fractures
| Author, year | Study design | Sample size | Percent of Women | Fracture outcomes | Mean age | Exposure assessment | Covariate adjustmenta | Country | NOS score | Items that did not earn a NOS score |
|---|---|---|---|---|---|---|---|---|---|---|
| Feskanich, 2002 [ | Cohort | 72,337 | 100 | Hip fracture | 60 | FFQ: Self-reported | 1, 7, 8, 14, 15, 16, 17, 18, 19, 20 | USA | 7 | - Study controls for any additional factor - Complete follow up, all subjects accounted for |
| Zhang, 2006 [ | C-C | 2564 | 69.2 | Hip fracture | 75.2 | FFQ: Self-reported | 1, 2, 8, 9, 11, 12, 14, 18, 19, 21 | USA | 9 | |
| Sahni, 2009 [ | Cohort | 1046 | 61 | Hip fracture | 75 | FFQ: Self-reported | 1, 2, 8, 9, 12, 14, 19, 21, 22 | USA | 8 | - Truly representative of the average sample in the community |
| Ambrosini, 2013 [ | Cohort | 2322 | 28.6 | Any fracture | 55 | Medical records | 1, 2, 6, 8, 14, 23 | Australia | 5 | - Truly representative of the average sample in the community - Independent blind assessment - Study controls for any additional factor - Complete follow up, all subjects accounted for |
| Sun, 2014 [ | C-C | 1452 | NA | Hip fracture | 70.5 | FFQ: Self-reported | 1,2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14 | China | 7 | - Consecutive or representative series of cases - Community controls |
| Dai, 2014 [ | Cohort | 63,154 | 55.8 | Hip fracture | 56.3 | FFQ: Self-reported | 1, 3, 8, 9, 11, 12, 14, 15, 24, 25, 26, 27, 28 | Singapore/China | 7 | - Complete follow up, all subjects accounted for - Independent blind assessment |
| Jonge, 2015 [ | Cohort | 5288 | 58.9 | Any fracture | 67 | FFQ: Self-reported | 1, 2, 3, 5, 8, 9, 11, 14, 29 | Netherland | 8 | - Selected an adequate follow up period for outcome of interest |
| Hayhoe, 2017 [ | Cohort | 40,242 | 55.3 | Any/hip/spine fracture | 60.8 | 7-day food diaries | 1, 6, 7, 8, 9, 11, 12, 14, 15, 30, 31 | UK | 9 | |
| Cao, 2018 [ | C-C | 2140 | 74.1 | Hip fracture | 70.6 | FFQ: Self-reported | 1, 3, 4, 5, 6, 7, 8, 10, 11, 12, 14, 32 | China | 5 | - Consecutive or representative series of cases - Study controls for any additional factor - Same method of ascertainment for cases and controls - Same non-response rate for both groups |
Abbreviations: C-C case-control, FFQ food frequency questionnaire, NA not available, UK United Kingdomm, US United States,
aAge (1), sex (2), educational level (3), occupation (4), household income (5), family history of fracture (6), smoking status (7), alcohol intake (8), calcium use (9), multivitamin supplement use (10), physical activity (11), daily energy intake (12), dietary intake of selected nutrients (13), body mass index (14), use of postmenopausal hormones (15), hours of leisure-time activity (16), use of thiazide diuretics (17), protein use (18), vitamin D (19), vitamin K (20), caffeine use (21), height (22), medication use (23), dialect group (24), vitamin B6 (25), soy isoflavones (26), history of diabetes and stroke (27), use of hormone replacement therapy (28), disability index (29), hormone replacement therapy (30), corticosteroid use (31), and calcium supplement use (32)
Fig. 2Forest plot of β-carotene intake and risk of fracture for all studies utilizing the traditional meta-analysis
Association between β-carotene intake and risk of fracture under the Bayesian meta-analysis
| Subgroup | No. of studies | RR (95% CrI) | Probability (%) that the RR is: | ||
|---|---|---|---|---|---|
| ≤ 1.0 | ≤ 0.9 | ≤ 0.8 | |||
| Overall studies | 9 | 0.67 (0.51, 0.82) | 1.00 | 0.99 | 0.95 |
| Hip fracture | 6 | 0.63 (0.44, 0.82) | 0.99 | 0.99 | 0.95 |
| By study design | |||||
| Case-control studies | 3 | 0.55 (0.14, 0.96) | 0.95 | 0.92 | 0.88 |
| Cohort studies | 6 | 0.82 (0.58, 0.99) | 0.92 | 0.77 | 0.45 |
| By Geographic region | |||||
| US | 3 | 0.86 (0.35, 1.37) | 0.75 | 0.62 | 0.46 |
| Europe | 3 | 0.91 (0.75, 1.00) | 0.91 | 0.44 | 0.10 |
| China/ Singapore | 3 | 0.58 (0.28, 0.89) | 0.97 | 0.95 | 0.91 |
| By Sex | |||||
| Females | 8 | 0.76 (0.44, 1.07) | 0.92 | 0.83 | 0.66 |
| Males | 6 | 0.88 (0.73, 0.99) | 0.91 | 0.85 | 0.75 |
Abreviation: RR risk ratio, 95% CrI 95% credible interval
Fig. 3Forest plot of associations between β-carotene intake and risk of fractures under the traditional meta-analysis method, by case-control and cohort studies
Fig. 4Funnel plot of publication bias, risk ratio versus standard error